Cargando…
Chitosan IFN-γ-pDNA Nanoparticle (CIN) Therapy for Allergic Asthma
BACKGROUND: Allergic subjects produce relatively low amounts of IFN-γ, a pleiotropic Th-1 cytokine that downregulates Th2-associated airway inflammation and hyperresponsiveness (AHR), the hallmarks of allergic asthma. Adenovirus-mediated IFN-γ gene transfer reduces AHR, Th2 cytokine levels and lung...
Autores principales: | Kumar, Mukesh, Kong, Xiaoyuan, Behera, Aruna K, Hellermann, Gary R, Lockey, Richard F, Mohapatra, Shyam S |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC280670/ https://www.ncbi.nlm.nih.gov/pubmed/14613519 http://dx.doi.org/10.1186/1479-0556-1-3 |
Ejemplares similares
-
Chitosan Interferon-γ Nanogene Therapy for Lung Disease: Modulation of T-Cell and Dendritic Cell Immune Responses
por: Kong, Xiaoyuan, et al.
Publicado: (2008) -
An immunocompromised BALB/c mouse model for respiratory syncytial virus infection
por: Kong, Xiaoyuan, et al.
Publicado: (2005) -
Modulation of lung inflammation by vessel dilator in a mouse model of allergic asthma
por: Wang, Xiaoqin, et al.
Publicado: (2009) -
Regulating the Regulators: microRNA and Asthma
por: Wang, Jia-wang, et al.
Publicado: (2011) -
Mechanism of cigarette smoke condensate-induced acute inflammatory response in human bronchial epithelial cells
por: Hellermann, Gary R, et al.
Publicado: (2002)